PREDICTORS OF LATE TARGET LESION REVASCULARIZATION AFTER ENDEAVOR AND RESOLUTE ZOTAROLIMUS–ELUTING STENT IMPLANTATION: 3D–INTRAVASCULAR ULTRASOUND AND ANGIOGRAPHIC ANALYSES  by Kitahara, Hideki et al.
E1777
JACC March 12, 2013
Volume 61, Issue 10
TCT@ACC-i2: Invasive and Interventional Cardiology
predicTors of laTe TargeT lesion revascularizaTion afTer endeavor and resoluTe 
zoTarolimus-eluTing sTenT implanTaTion: 3d-inTravascular ulTrasound and 
angiographic analyses
Moderated Poster Contributions
Poster Sessions, Expo North
Sunday, March 10, 2013, 9:45 a.m.-10:30 a.m.
Session Title: Intravascular Imaging: IVUS and OCT
Abstract Category: 38. TCT@ACC-i2: Intravascular Imaging and Physiology
Presentation Number: 2108M-235
Authors: Hideki Kitahara, Teruyoshi Kume, Katsuhisa Waseda, Kenji Sakamoto, Ryotaro Yamada, Paul G. Yock, Alan C. Yeung, Peter J. Fitzgerald, 
Yasuhiro Honda, Stanford University, Stanford, CA, USA
Background: The aim of this study was to evaluate whether IVUS or angiographic parameters during mid-term follow-up (FU) can predict late 
target lesion revascularization (TLR) in lesions treated with Endeavor (E-ZES) and Resolute zotarolimus-eluting stents (R-ZES).
methods: Clinical outcomes were followed for up to 5 years in 953 lesions (753 E-ZES; 200 R-ZES) with no TLR within the first 12 months. 
Quantitative angiography and volumetric IVUS were performed at baseline (BL) and mid-term (9-12 months) FU.
results:  Late-TLR (>12 months) occurred in 1.3% of E-ZES and 4.0% of R-ZES lesions. The amount of neointima at mid-term FU did not predict the 
late-TLR in either stents. In E-ZES, lumen dimensions at mid-term FU tended to be smaller in late-TLR, whereas they did not predict late-TLR in R-ZES. 
Serial IVUS showed stable and comparable peri-stent dimensions in E-ZES between late-TLR vs no-TLR lesions. In contrast, late-TLR of R-ZES had 
larger plaque at BL, followed by greater increases of vessel and plaque from BL to mid-term FU, resulting in larger vessel and plaque at mid-term FU 
compared with no-TLR lesions.
conclusions: This study suggests that the determinants of late-TLR depend on the type of drug carrier and release kinetics. The low incidence of 
late-TLR and no significant change of the stented vessel may represent healing and stability of the treated vessel after E-ZES implantation. Late-TLR 
of R-ZES appears to be related to arterial responses of the stented vessel observed during the first 9-12 months.
Comparisons Between Late vs. no-TLR Lesions Treated with E-ZES and R-ZES
Endeavor Resolute
Late-TLR
(n=10)
No-TLR
(n=743)
p
Late-TLR
(n=8)
No-TLR
(n=192)
p
IVUS
Baseline
Vessel volume (mm3/mm) 13.4±6.0 14.1±4.9 0.709 16.7±6.0 14.0±3.9 0.110
Plaque volume (mm3/mm) 7.0±4.8 7.0±2.9 0.979 8.8±4.0 6.6±2.5 0.047
Mid-term FU
Vessel volume (mm3/mm) 14.1±7.1 14.8±4.1 0.695 18.8±7.1 13.8±3.9 0.008
Plaque volume (mm3/mm) 7.9±5.6 7.6±2.6 0.783 10.2±4.6 6.7±2.3 0.002
Minimum lumen area (mm2) 4.0±1.8 4.9±1.7 0.208 5.9±1.5 5.7±1.8 0.780
Neointimal obstruction (%) 15.6±7.2 15.5±10.0 0.989 4.6±4.3 4.1±4.6 0.783
From baseline to mid-term FU
Δ vessel volume (mm3/mm) 0.4±0.3 0.2±1.7 0.855 1.3±0.8 0.2±1.1 0.031
Δ plaque volume (mm3/mm) 0.4±0.3 0.09±1.1 0.535 0.8±0.5 0.1±0.6 0.023
Angiography at mid-term FU
Minimum lumen diameter (mm) 1.8±0.5 2.1±0.5 0.097 2.3±0.3 2.4±0.5 0.738
Diameter stenosis (%) 28.9±20.8 23.0±13.7 0.230 17.7±12.2 10.3±13.9 0.165
Late lumen loss (mm) 0.7±0.4 0.6±0.4 0.306 0.4±0.4 0.2±0.3 0.110
